LNTH Lantheus Holdings Inc

USD 58.64 1.14 (+1.98%)
At close: 04:00PM EST
Icon

Lantheus Holdings Inc Stock Analysis and Price Target COMMON STOCK | Drug Manufacturers-Specialty & Generic | NSD

N/A

Average User
Rating
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis

USD 58.64

+1.14 (+1.98)%

USD 3.86B

1.02M

USD 109.75(+87.16%)

N/A

Icon

LNTH

Lantheus Holdings Inc (USD)
COMMON STOCK | NSD
USD 58.64
1.14 (+1.98%)
At close: 04:00PM EST

N/A

Average User
Rating
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis

USD 3.86B

N/A

USD 58.64

Lantheus Holdings Inc Stock Forecast

USD 109.75
(+87.16%)

Based on the Lantheus Holdings Inc stock forecasts from 3 analysts, the average analyst target price for Lantheus Holdings Inc is USD 109.75 over the next 12 months. Lantheus Holdings Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Lantheus Holdings Inc is Slightly Bearish, which is based on 6 positive signals and 8 negative signals. At the last closing, Lantheus Holdings Inc’s stock price was USD 58.64. Lantheus Holdings Inc’s stock price has changed by +7.30% over the past week, +15.07% over the past month and +126.32% over the last year.

No recent analyst target price found for Lantheus Holdings Inc
No recent average analyst rating found for Lantheus Holdings Inc

Company Overview

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultr...Read More

https://www.lantheus.com

331 Treble Cove Road, North Billerica, MA, United States, 01862

612

December

USD

USA

Adjusted Closing Price

Loading...

Technical Indicators

  • 0.77

  • USD 87.47

  • 3.85

  • USD 25.49

  • 3,451,813

  • USD 65.88

  • 3,648,263

  • USD 54.20

  • 2.40%

  • 6.02%

  • 101.30%

  • N/A

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Security Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To Lantheus Holdings Inc (Sector: Drug Manufacturers-Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
PPD
PPD Inc 0.00 (0.00%) USD16.61B 47.04 21.58
VTRS
Viatris Inc +0.10 (+0.82%) USD14.42B 18.02 6.97
NBIX
Neurocrine Biosciences Inc -0.71 (-0.64%) USD10.41B 180.48 98.51
MYL
Mylan N.V 0.00 (0.00%) USD8.59B 30.73 11.86
APHA
Tilray, Inc 0.00 (0.00%) USD6.86B 60.60 454.68
MNTA
Momenta Pharmaceuticals, Inc 0.00 (0.00%) USD6.24B N/A N/A
ALKS
Alkermes Plc +0.05 (+0.17%) USD4.73B N/A -72.85
ITCI
Intracellular Th -0.10 (-0.21%) USD4.45B N/A -14.58
EVO
Evotec SE ADR +0.10 (+1.03%) USD3.66B 508.00 -19.09
HCM
HUTCHMED DRC +0.73 (+4.05%) USD3.64B 17.69 -6.38

ETFs Containing LNTH

Symbol Name Weight Mer Price(Change) Market Cap
AVSC
American Century ETF Trus.. 0.48 % 0.25 % +0.68 (+1.43%) USD0.11B
SAA
ProShares Ultra SmallCap6.. 0.46 % 0.95 % +0.74 (+3.02%) USD0.03B

Frequently Asked Questions About LNTH Stock

Based on ratings from 3 analysts Lantheus Holdings Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 5 buy, sell and hold ratings.

Unfortunately we do not have enough data on LNTH's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for LNTH is USD 109.75 over the next 12 months. The maximum analyst target price is USD 120 while the minimum anlayst target price is USD 104.

LNTH stock's Price/Earning ratio is 36.91. Our analysis grades LNTH stock's Price / Earning ratio at F. This means that LNTH stock's Price/Earning ratio is above 62% of the stocks in the Drug Manufacturers-Specialty & Generic sector in the NSD exchange. Based on this LNTH may be a overvalued for its sector.

The last closing price of LNTH's stock was USD 58.64.

The most recent market capitalization for LNTH is USD 3.86B.

Based on targets from 3 analysts, the average taret price for LNTH is projected at USD 109.75 over the next 12 months. This means that LNTH's stock price may go up by +87.16% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...